Literature DB >> 20460385

Effect of dimerized thrombin fragment TP508 on acute myocardial ischemia reperfusion injury in hypercholesterolemic swine.

Shizu Oyamada1, Robert Osipov, Cesario Bianchi, Michael P Robich, Jun Feng, Yuhong Liu, Thomas A Burgess, Timothy M Bell, Michael R Sheller, Frank W Sellke.   

Abstract

The thrombin-related peptide TP508 is a 23-amino acid monomer that represents a portion of the receptor binding domain in the thrombin molecule. TP508 is also known to readily convert to a dimer in an aqueous environment. In this study the dimeric form of TP508 was investigated in a porcine model of acute myocardial ischemia reperfusion injury (and compared with its monomer). Twenty-four hypercholesterolemic pigs underwent 60 min of mid-left anterior descending coronary artery occlusion followed by 120 min of reperfusion and received either vehicle (n = 6), TP508 monomer (n = 6), or two different doses of dimer (n = 6). Infarct size was significantly reduced in the monomer and two dimer groups compared with vehicle. Improvement in both endothelium-dependent and -independent coronary microvascular relaxations was also observed in treated groups. In addition, the expression of 27-kDa heat shock protein, alphaB-crystalline, and phosphorylated B-cell lymphoma 2 (Ser70) in the ischemic area at risk were higher in treated groups than in vehicle, whereas the expression of cleaved poly-ADP ribose polymerase was lower in treated groups. Finally, there were fewer apoptotic cells in treated groups than in vehicle. This study suggests that TP508 dimer provides a myocardial-protective effect on acute ischemia reperfusion injury in hypercholesterolemic swine, similar to TP508 monomer, by up-regulating cell survival pathways or down-regulating apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460385      PMCID: PMC2913770          DOI: 10.1124/jpet.110.166348

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  37 in total

1.  Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival.

Authors:  Susanna C Benn; Daniel Perrelet; Ann C Kato; Joachim Scholz; Isabelle Decosterd; Richard J Mannion; Joanna C Bakowska; Clifford J Woolf
Journal:  Neuron       Date:  2002-09-26       Impact factor: 17.173

2.  Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c.

Authors:  C G Concannon; S Orrenius; A Samali
Journal:  Gene Expr       Date:  2001

3.  Novel role for JNK as a stress-activated Bcl2 kinase.

Authors:  X Deng; L Xiao; W Lang; F Gao; P Ruvolo; W S May
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

4.  Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3.

Authors:  P Pandey; R Farber; A Nakazawa; S Kumar; A Bharti; C Nalin; R Weichselbaum; D Kufe; S Kharbanda
Journal:  Oncogene       Date:  2000-04-13       Impact factor: 9.867

5.  HSP27 inhibits cytochrome c-dependent activation of procaspase-9.

Authors:  C Garrido; J M Bruey; A Fromentin; A Hammann; A P Arrigo; E Solary
Journal:  FASEB J       Date:  1999-11       Impact factor: 5.191

6.  A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo.

Authors:  D R Knight; A H Smith; D M Flynn; J T MacAndrew; S S Ellery; J X Kong; R B Marala; R T Wester; A Guzman-Perez; R J Hill; W P Magee; W R Tracey
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

7.  Hsp27 as a negative regulator of cytochrome C release.

Authors:  Catherine Paul; Florence Manero; Sandrine Gonin; Carole Kretz-Remy; Sophie Virot; André-Patrick Arrigo
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

8.  Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli.

Authors:  A Samali; J D Robertson; E Peterson; F Manero; L van Zeijl; C Paul; I A Cotgreave; A P Arrigo; S Orrenius
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

Review 9.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

10.  Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine.

Authors:  Claus U Niemann; Maythem Saeed; Haydar Akbari; Wolfgang Jacobsen; Leslie Z Benet; Uwe Christians; Natalie Serkova
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

View more
  1 in total

1.  Radiomitigation and Tissue Repair Activity of Systemically Administered Therapeutic Peptide TP508 Is Enhanced by PEGylation.

Authors:  Scott D McVicar; Kempaiah Rayavara; Darrell H Carney
Journal:  AAPS J       Date:  2017-01-17       Impact factor: 4.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.